SUZHOU NANOMICRO TECHNOLOGY CO LTD

Overview

SUZHOU NANOMICRO TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 12 active FDA Type II Drug Master Files, covering NANOGEL 50Q HC; NANOGEL 50SP HP; NANOGEL-DT20; NANOQ-30L; NM CHT; NM90AGAROSE HCM.

API / Drug Master Files

SUZHOU NANOMICRO TECHNOLOGY CO LTD holds 12 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• NANOGEL-DT20Active2025-04-10
• NM90AGAROSE HCMActive2025-02-20
• UNIGEL-30DEAEActive2025-02-20
• NANOQ-30LActive2024-11-28
• NANOGEL 50Q HCActive2024-06-06
• NM CHTActive2024-06-05
• NMabActive2024-06-05
• NMAB TITANActive2024-06-05
• NANOGEL 50SP HPActive2023-02-17
• UNIGEL 65Q HCActive2023-02-17
• NMAB PRO PROTEIN A AFFINITY RESINActive2023-02-17
• UNIMAB 50HCActive2022-03-17

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SUZHOU NANOMICRO TECHNOLOGY CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.